Literature DB >> 16111466

Current role of image-guided ablative therapies in lung cancer.

Caroline J Simon1, Damian E Dupuy.   

Abstract

Lung cancer is the leading cause of cancer-related mortality in the USA. Until recently, lung cancer treatment options (dependent upon the tumor grading and staging at presentation, and patient comorbidities) included surgical resection (lobar or sublobar), chemotherapy and external-beam radiation therapy. While these options are still viewed as the primary standard of care, newer minimally invasive percutaneous ablative techniques such as radiofrequency ablation, microwave ablation and cryoablation are currently being examined as treatment alternatives, especially in the setting of the nonsurgical candidate. This review will focus on these three distinct thermoablative techniques in the percutaneous setting of lung cancer treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16111466     DOI: 10.1586/14737140.5.4.657

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  15 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer.

Authors:  Yi-Ping Zou; Wei-Min Li; Fang Zheng; Fu-Cheng Li; Hui Huang; Ji-Dong Du; Hao-Run Liu
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

3.  Radiofrequency-assisted partial splenectomy: Histopathological and immunological assessment of the splenic remnant in a porcine model.

Authors:  Dimitris Zacharoulis; Antigoni Poultsidis; Emmanuel Katsogridakis; Fani Kalala; Marianna Nakou; Constantine Chatzitheofilou
Journal:  Surg Endosc       Date:  2007-11-20       Impact factor: 4.584

Review 4.  Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?

Authors:  Millie Das; Mohamed H K Abdelmaksoud; Billy W Loo; Nishita Kothary
Journal:  Curr Treat Options Oncol       Date:  2010-06

Review 5.  Endoscopic palliation of malignant biliary strictures.

Authors:  Sanjay M Salgado; Monica Gaidhane; Michel Kahaleh
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

6.  Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma.

Authors:  Roberto Girelli; Isabella Frigerio; Alessandro Giardino; Paolo Regi; Stefano Gobbo; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2012-09-29       Impact factor: 3.445

7.  Cryosurgery for lung cancer.

Authors:  Lizhi Niu; Kecheng Xu; Feng Mu
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

Review 8.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

Review 9.  Endoscopic ultrasound-guided radiofrequency ablation in gastroenterology: New horizons in search.

Authors:  Satyarth Chaudhary; Si-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

10.  The problems of radiofrequency ablation as an approach for advanced unresectable ductal pancreatic carcinoma.

Authors:  Raffaele Pezzilli; Claudio Ricci; Carla Serra; Riccardo Casadei; Francesco Monari; Marielda D'Ambra; Roberto Corinaldesi; Francesco Minni
Journal:  Cancers (Basel)       Date:  2010-07-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.